These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 15879000)

  • 81. Guanidino compound metabolism in rats subjected to 20% to 90% nephrectomy.
    Levillain O; Marescau B; de Deyn PP
    Kidney Int; 1995 Feb; 47(2):464-72. PubMed ID: 7536856
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Accumulation and excretion of middle molecules.
    Asaba H
    Clin Nephrol; 1983 Mar; 19(3):116-23. PubMed ID: 6839560
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Renal clearance of salicylic acid and salicyluric acid in the rat and in the isolated perfused rat kidney.
    Bekersky I; Fishman L; Kaplan SA; Colburn WA
    J Pharmacol Exp Ther; 1980 Feb; 212(2):309-14. PubMed ID: 7351644
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [The slope clearance method in renal functional diagnosis. J-131-hippurate clearance is used as an example].
    Böttcher M; Neumann J; Esther G; Wüstenberg PW
    Z Gesamte Inn Med; 1979 Oct; 34(19):586-8. PubMed ID: 543180
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Mechanistic Study on the Effect of Renal Impairment on the Pharmacokinetics of Vildagliptin and its Carboxylic Acid Metabolite.
    Guo Z; Kong F; Xie N; Chen Z; Hu J; Chen X
    Pharm Res; 2022 Sep; 39(9):2147-2162. PubMed ID: 35790618
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Plasma OLC is elevated in mild experimental uremia but is not associated with hypertension.
    Harwood S; Mullen AM; McMahon AC; Dawnay A
    Am J Hypertens; 2001 Nov; 14(11 Pt 1):1112-5. PubMed ID: 11724209
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [The effect of dipyridamole on hippurate excretion in healthy volunteers and in patients with renal insufficiency].
    Gajdos M; Spustová V; Stefíková K; Dzúrik R
    Cas Lek Cesk; 1991 Nov; 130(20-21):598-600. PubMed ID: 1769055
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Pathogenesis of hyperprolactinemia in uremic rats.
    Martín-Oar JE; Peces R; Ramos B; López-Novoa JM; Hernando L
    Endocrinology; 1981 Jun; 108(6):2283-6. PubMed ID: 7227307
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Plasma clearance in the rat of a furan dicarboxylic acid which accumulates in uremia.
    Costigan MG; Lindup WE
    Kidney Int; 1996 Mar; 49(3):634-8. PubMed ID: 8648903
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Hippurate participation in the inhibition of glucose utilization in renal failure.
    Spustová V; Dzúrik R; Geryková M
    Czech Med; 1987; 10(2):79-89. PubMed ID: 3115738
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Albumin-bound kynurenic acid is an appropriate endogenous biomarker for assessment of the renal tubular OATs-MRP4 channel.
    Ma Y; Ran F; Xin M; Gou X; Wang X; Wu X
    J Pharm Anal; 2023 Oct; 13(10):1205-1220. PubMed ID: 38024860
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The rebirth of interest in renal tubular function.
    Lowenstein J; Grantham JJ
    Am J Physiol Renal Physiol; 2016 Jun; 310(11):F1351-5. PubMed ID: 26936872
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Impairment of methylamine clearance in uremic patients and its nephropathological implications.
    Yu PH; Dyck RF
    Clin Nephrol; 1998 May; 49(5):299-302. PubMed ID: 9617493
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Biliary amino acid excretion in rats before and after bilateral nephrectomy.
    Fleck C
    Physiol Res; 1992; 41(4):273-8. PubMed ID: 1286095
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Immunohistochemical and electron-microscopic identification of neuroendocrine cells in the stomach of uremic rats.
    Kasacka I
    Cell Biol Int; 2004; 28(6):441-7. PubMed ID: 15223020
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Establishment and use of surgical rat models for assessment of organ specific in vivo clearance.
    Vestergaard B
    Dan Med J; 2016 Jun; 63(6):. PubMed ID: 27264946
    [TBL] [Abstract][Full Text] [Related]  

  • 97. SLCO4C1 transporter eliminates uremic toxins and attenuates hypertension and renal inflammation.
    Toyohara T; Suzuki T; Morimoto R; Akiyama Y; Souma T; Shiwaku HO; Takeuchi Y; Mishima E; Abe M; Tanemoto M; Masuda S; Kawano H; Maemura K; Nakayama M; Sato H; Mikkaichi T; Yamaguchi H; Fukui S; Fukumoto Y; Shimokawa H; Inui K; Terasaki T; Goto J; Ito S; Hishinuma T; Rubera I; Tauc M; Fujii-Kuriyama Y; Yabuuchi H; Moriyama Y; Soga T; Abe T
    J Am Soc Nephrol; 2009 Dec; 20(12):2546-55. PubMed ID: 19875811
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Liver function after bilateral nephrectomy.
    Fleck C; Börner A; Kretzschmar M; Machnik G; Sprott H; Zimmermann T; Keil E; Bräunlich H
    Liver; 1992 Oct; 12(5):319-25. PubMed ID: 1447965
    [TBL] [Abstract][Full Text] [Related]  

  • 99. The renal transport of hippurate and protein-bound solutes.
    Kumar R; Adiga A; Novack J; Etinger A; Chinitz L; Slater J; de Loor H; Meijers B; Holzman RS; Lowenstein J
    Physiol Rep; 2020 Feb; 8(4):e14349. PubMed ID: 32097533
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Drug-induced changes in renal hippurate clearance as a measure of renal blood flow.
    Visscher CA; de Zeeuw D; de Jong PE; Sluiter WJ; Huisman RM
    Kidney Int; 1995 Nov; 48(5):1617-23. PubMed ID: 8544423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.